« Back
Home /
Lyn peptide inhibitor

Lyn peptide inhibitor

Item no.	TMO-TP2008-1mg
Manufacturer	TargetMol
CASRN	222018-18-0
Amount	1 mg
Category	Peptides & Proteins Cardiovascular Research Atherosclerosis Peptides
Type	Peptides
Specific against	other
Smiles	C([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC1=CC=C(O)C=C1)NC(CNC([C@H](CC2=CC=C(O)C=C2)NC(CCCCCCCCCCCCCCCCC)=O)=O)=O)=O)CCCNC(=N)N)=O)CC(C)C)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCCCN)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(=O)N3[C@H](C(N[C@H](C(=O)N4[C@H](C(N)=O)CCC4)CC(N)=O)=O)CCC3)[C@H](CC)C)=O)CCCCN)=O)CCC(O)=O)=O)CCC(O)=O)=O)C=5C=6C(NC5)=CC=CC6
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Shipping Condition	Cool pack
Available
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	2370.91
Description	Cell-permeable inhibitor of Lyn-dependent effects of the IL-5 receptor. Blocks binding of Lyn tyrosine kinase to βc subunit of IL-3/GM-CSF/IL-5 receptors, blocking Lyn activation. Inhibits IL-5 receptor-mediated eosinophil differentiation and survival in vitro. Inhibits airway eosinophilic inflammation in mouse model of asthma.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-TP2008-1mg-datasheet.pdf

TMO-TP2008-1mg-safety-datasheet.pdf